Emcure Pharmaceuticals Limited (BOM:544210)
991.60
-4.40 (-0.44%)
At close: Feb 20, 2025
Emcure Pharmaceuticals Statistics
Total Valuation
BOM:544210 has a market cap or net worth of INR 188.63 billion. The enterprise value is 200.04 billion.
Market Cap | 188.63B |
Enterprise Value | 200.04B |
Important Dates
The last earnings date was Thursday, February 6, 2025.
Earnings Date | Feb 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +2.25% |
Shares Change (QoQ) | +0.51% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 20.33M |
Valuation Ratios
The trailing PE ratio is 31.05.
PE Ratio | 31.05 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 6.05 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 32.93 |
EV / Sales | 2.65 |
EV / EBITDA | 14.87 |
EV / EBIT | 19.76 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.28 |
Debt / EBITDA | 0.88 |
Debt / FCF | n/a |
Interest Coverage | 6.33 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 6.96M |
Profits Per Employee | 559,844 |
Employee Count | 10,852 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 1,288.76 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 27.44 |
Average Volume (20 Days) | 10,880 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544210 had revenue of INR 75.51 billion and earned 6.08 billion in profits. Earnings per share was 32.85.
Revenue | 75.51B |
Gross Profit | 45.65B |
Operating Income | 10.12B |
Pretax Income | 8.78B |
Net Income | 6.08B |
EBITDA | 13.06B |
EBIT | 10.12B |
Earnings Per Share (EPS) | 32.85 |
Balance Sheet
The company has 2.32 billion in cash and 11.89 billion in debt, giving a net cash position of -9.56 billion.
Cash & Cash Equivalents | 2.32B |
Total Debt | 11.89B |
Net Cash | -9.56B |
Net Cash Per Share | n/a |
Equity (Book Value) | 43.03B |
Book Value Per Share | 218.65 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 60.46%, with operating and profit margins of 13.41% and 8.05%.
Gross Margin | 60.46% |
Operating Margin | 13.41% |
Pretax Margin | 11.62% |
Profit Margin | 8.05% |
EBITDA Margin | 17.29% |
EBIT Margin | 13.41% |
FCF Margin | n/a |
Dividends & Yields
BOM:544210 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.25% |
Shareholder Yield | -2.25% |
Earnings Yield | 3.22% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |